What is more, in ITA, transplant from 358 (95.5%) patients from the double-vessel CAD group and 911 (96.6%) patients from the triple-vessel CAD group lack of CAV2 protein within SMCs was accompanied by VEGF-C positive expression (Fig. 10a, b). This evidence concerns the gene CAV2 and coronary artery disorder.